Covestor’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Sell
8
-6
-43% -$257 ﹤0.01% 2858
2026
Q2
$1K Buy
14
+8
+133% +$217 ﹤0.01% 2369
2026
Q1
$0 Buy
+6
New – ﹤0.01% 2799
2025
Q4
– Sell
-68
Closed -$1K – 2763
2025
Q3
$1K Buy
+68
New +$1.22K ﹤0.01% 2197

Other funds holding URGN

Covestor's URGN Position: Q3 2026 in Review

Covestor reduced its UroGen Pharma (URGN) stake by 43% in Q3 2026, selling an estimated $257 and leaving 8 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2858.

Covestor first reported a position in URGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $1K in Q2 2026. 221 funds tracked by Wall St. Rank hold URGN as of Q3 2026.

  • Covestor held 8 shares of UroGen Pharma worth $0 as of Q3 2026.
  • Covestor sold 6 UroGen Pharma shares in Q3 2026, an estimated $257.
  • UroGen Pharma made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2858 holding.
  • Covestor first reported a position in UroGen Pharma in Q3 2025 and has held it in 4 quarters since.
  • Covestor's UroGen Pharma position peaked at $1K in Q2 2026.
  • 221 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.